EGFR and glioblastoma: Antagonistic relationships between miR-218 and EGFR have also been demonstrated in glioblastoma (Mathew et al. 2015) and, indirectly, in osteosarcoma (Lin et al. 2020) and esophageal squamous cell carcinoma (Qu et al. 2020).